Small, medium-sized pharma firms gear up to comply with revised Schedule M

Pharma groups had wanted two year extension, will raise concerns with govt

Small and medium-sized pharmaceutical companies are preparing to comply with the provisions of the revised Schedule M, which is upgrading facilities and maintaining good manufacturing practices, within the extended deadline of December 31, even as pharma lobby groups have raised concern about completing the job within target.

 

On January 4, the Ministry of Health and Family Welfare issued a draft notification proposing a one-year extension for small and medium-sized companies (with an annual turnover of less than Rs 250 crore) to upgrade facilities in accordance with the revised Schedule M of the Drugs and Cosmetics Act.

 

While lobby groups had